- Home
- FTHM vs RLYB Comparison
FTHM vs RLYB Comparison
Compare FTHM & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | RLYB |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 28.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FTHM | RLYB |
|---|---|---|
| Price | $1.00 | $7.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 102.1K | 94.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.21 | ★ 27.72 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $335,184,000.00 | $600,000.00 |
| Revenue This Year | $30.07 | $17.61 |
| Revenue Next Year | $14.66 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.22 |
| 52 Week High | $3.37 | $6.71 |
Technical Indicators
Market Signals| Indicator | FTHM | RLYB |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 91.81 |
| Support Level | $0.90 | $0.48 |
| Resistance Level | $1.50 | N/A |
| Average True Range (ATR) | 0.08 | 0.59 |
| MACD | 0.00 | 0.25 |
| Stochastic Oscillator | 34.52 | 93.92 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.